Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CRBP will decline by -8.94% over the next 2 Weeks and hit $7.80 by Friday, March 13, 2026. In that time frame, CRBP's share price is expected to range between $7.39 and $8.17.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 16, 2026 | 7.56 | 8.03 | 8.50 |
| Mar 13, 2026 | 7.51 | 8.00 | 8.46 |
| Mar 12, 2026 | 7.69 | 8.18 | 8.65 |
| Mar 11, 2026 | 7.65 | 8.14 | 8.59 |
| Mar 10, 2026 | 7.77 | 8.26 | 8.77 |
| Mar 9, 2026 | 7.74 | 8.25 | 8.74 |
| Mar 6, 2026 | 7.74 | 8.22 | 8.70 |
| Mar 5, 2026 | 7.93 | 8.41 | 8.87 |
| Mar 4, 2026 | 7.89 | 8.36 | 8.84 |
| Mar 3, 2026 | 8.04 | 8.48 | 8.94 |
CRBP shares fell -2.57% in Monday, March 2, 2026's trading session, dropping from a previous close of $8.57 to move at $8.35. The stock demonstrated notable intraday movement (see CRBP's key stats for a full breakdown), fluctuating between $8.10 and $8.57, a +5.80% trading range. While recent weeks have seen some volatility, CRBP has managed to secure a +11.04% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 178.68K shares changing hands, 128.84K fewer than the previous session. This amounted to $1.49M in total market activity.
Will CRBP Continue Its Upward Trend?
According to analyst ratings and projections for CRBP, Corbus Pharmaceuticals Holdings, Inc. shares are anticipated to increase by +1.77%, potentially reaching $8.50 per share by March 16, 2026. Short-term technical indicators currently suggest a neutral sentiment for CRBP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the CRBP stock forecast, now is a good time to buy CRBP stock because its current trading price is +3.96% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CRBP covering social and institutional perspectives.
CRBP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CRBP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.65% to 60.43%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.59%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.94%, maintains a neutral outlook for the long term. Insights into CRBP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Corbus Pharmaceuticals Short-Term Forecasts
CRBP Forecast For Next 5 Days
Our algorithm anticipates Corbus Pharmaceuticals (CRBP) stock could hit $8.47 by Mar 09, 2026. This represents a +1.39% rise from today's price, following a +7.51% change over the past five days.
CRBP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $7.91, which would mean a -5.27% decrease from the current price of $8.35. Projections for this period range from a high of $9.56 to a low of $6.67.
CRBP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Corbus Pharmaceuticals's price over the next three months point to a rise. CRBP stock is expected to peak at $33.32 on Jun 01, 2026 after potentially dipping to $13.23 on Mar 03, 2026. On average, CRBP is likely to trade around $22.63 in the coming 90 days.
Corbus Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Corbus Pharmaceuticals (CRBP) is expected to trade between $1.19 and $72.77 throughout 2026. This would result in an average price of $27.76, potentially offering investors a +232.46% return from current levels.
Corbus Pharmaceuticals Holdings, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Corbus Pharmaceuticals Holdings, Inc. (CRBP) is positioned to show a strong performance in March 2026. The price is predicted to move between $13.23 and $28.30, settling at an average of $23.25. This could translate to a +178.44% gain.
April 2026
Based on current market signals, Corbus Pharmaceuticals Holdings, Inc. is projected to trend april 2026. We forecast a trading range from $14.38 to $23.20, with a likely average price of $17.71. Investors could expect a potential return of +112.10%.
May 2026
Our predictive algorithms indicate Corbus Pharmaceuticals Holdings, Inc. stock may see a shift in May 2026. The expected range spans $18.90–$33.22, with an average target of $26.29. This represents a positive outlook and a possible gain of +214.85%.
June 2026
Analyzing established trends, Corbus Pharmaceuticals Holdings, Inc. looks set to move in June 2026. Projections place the stock between $16.77 and $33.32, averaging around $24.88. This suggests a +197.96% gain from current levels.
July 2026
Market indicators suggest Corbus Pharmaceuticals Holdings, Inc. could experience notable changes during July 2026. Prices could fluctuate within $15.96 to $47.14, with a midpoint forecast of $28.98. The stock might deliver a +247.07% gain.
August 2026
Forecasting for August 2026, models estimate that Corbus Pharmaceuticals Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $42.62 and $72.56, averaging $57.27. This signals a positive trajectory with potential returns around +585.87%.
September 2026
According to our latest forecast models, Corbus Pharmaceuticals Holdings, Inc. (CRBP) is positioned to show a strong performance in September 2026. The price is predicted to move between $21.02 and $72.77, settling at an average of $43.54. This could translate to a +421.44% gain.
October 2026
Based on current market signals, Corbus Pharmaceuticals Holdings, Inc. is projected to trend october 2026. We forecast a trading range from $16.99 to $34.59, with a likely average price of $25.82. Investors could expect a potential return of +209.22%.
November 2026
Our predictive algorithms indicate Corbus Pharmaceuticals Holdings, Inc. stock may see a shift in November 2026. The expected range spans $7.58–$31.49, with an average target of $16.41. This represents a positive outlook and a possible gain of +96.53%.
December 2026
Analyzing established trends, Corbus Pharmaceuticals Holdings, Inc. looks set to move in December 2026. Projections place the stock between $1.19 and $38.04, averaging around $14.51. This suggests a +73.77% gain from current levels.
January 2027
Market indicators suggest Corbus Pharmaceuticals Holdings, Inc. could experience notable changes during January 2027. Prices could fluctuate within $28.23 to $54.37, with a midpoint forecast of $37.99. The stock might deliver a +354.97% gain.
February 2027
Forecasting for February 2027, models estimate that Corbus Pharmaceuticals Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.93 and $44.05, averaging $18.38. This signals a positive trajectory with potential returns around +120.12%.
March 2027
According to our latest forecast models, Corbus Pharmaceuticals Holdings, Inc. (CRBP) is positioned to show a strong performance in March 2027. The price is predicted to move between $23.05 and $37.45, settling at an average of $27.57. This could translate to a +230.18% gain.
CRBP's history of dividends and stock splits also plays a role in long-term investor confidence.